Targeting Chikungunya Virus Replication by Benzoannulene Inhibitors.

A benzo[6]annulene, 4-(tert-butyl)-N-(3-methoxy-5,6,7,8-tetrahydronaphthalen-2-yl) benzamide (1a), was identified as an inhibitor against Chikungunya virus (CHIKV) with antiviral activity EC90 = 1.45 μM and viral titer reduction (VTR) of 2.5 log at 10 μM with no observed cytotoxicity (CC50 = 169 μM) in normal human dermal fibroblast cells. Chemistry efforts to improve potency, efficacy, and drug-like properties of 1a resulted in a novel lead compound 8q, which possessed excellent cellular antiviral activity (EC90 = 270 nM and VTR of 4.5 log at 10 μM) and improved liver microsomal stability. CHIKV resistance to an analog of 1a, compound 1c, tracked to a mutation in the nsP3 macrodomain. Further mechanism of action studies showed compounds working through inhibition of human dihydroorotate dehydrogenase in addition to CHIKV nsP3 macrodomain. Moderate efficacy was observed in an in vivo CHIKV challenge mouse model for compound 8q as viral replication was rescued from the pyrimidine salvage pathway.

[1]  D. Streblow,et al.  Small Molecule Inhibitors Targeting Chikungunya Virus. , 2020, Current topics in microbiology and immunology.

[2]  Cláudio Cirne-Santos,et al.  Quinolone-N-acylhydrazone hybrids as potent Zika and Chikungunya virus inhibitors. , 2019, Bioorganic & medicinal chemistry letters.

[3]  M. Heise,et al.  Vaccine-Induced Skewing of T Cell Responses Protects Against Chikungunya Virus Disease , 2019, Front. Immunol..

[4]  Hongying Gao,et al.  Discovery, Optimization, and Target Identification of Novel Potent Broad-Spectrum Antiviral Inhibitors. , 2019, Journal of medicinal chemistry.

[5]  R. Davey,et al.  Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses , 2018, Antiviral research.

[6]  Jessica L Smith,et al.  Characterization and structure‐activity relationship analysis of a class of antiviral compounds that directly bind dengue virus capsid protein and are incorporated into virions , 2018, Antiviral research.

[7]  J. Dye,et al.  Optimization of Isothiazolo[4,3- b]pyridine-Based Inhibitors of Cyclin G Associated Kinase (GAK) with Broad-Spectrum Antiviral Activity. , 2018, Journal of medicinal chemistry.

[8]  P. Circosta,et al.  Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors. , 2018, Journal of medicinal chemistry.

[9]  L. Ng,et al.  Inhibition of the Replication of Different Strains of Chikungunya Virus by 3-Aryl-[1,2,3]triazolo[4,5- d]pyrimidin-7(6 H)-ones. , 2018, ACS infectious diseases.

[10]  J. Neyts,et al.  A reassessment of mycophenolic acid as a lead compound for the development of inhibitors of chikungunya virus replication , 2017 .

[11]  M. P. Pinheiro,et al.  The dihydroorotate dehydrogenases: Past and present. , 2017, Archives of biochemistry and biophysics.

[12]  B. Coutard,et al.  Antiviral activity of [1,2,3]triazolo[4,5‐d]pyrimidin‐7(6H)‐ones against chikungunya virus targeting the viral capping nsP1 , 2017, Antiviral research.

[13]  G. Leoncini,et al.  The medicinal chemistry of Chikungunya virus , 2017, Bioorganic & Medicinal Chemistry.

[14]  L. Ng,et al.  Structural Optimizations of Thieno[3,2-b]pyrrole Derivatives for the Development of Metabolically Stable Inhibitors of Chikungunya Virus. , 2017, Journal of medicinal chemistry.

[15]  Xiaoshan Huang,et al.  2,4,5-Trisubstituted thiazole derivatives as HIV-1 NNRTIs effective on both wild-type and mutant HIV-1 reverse transcriptase: Optimization of the substitution of positions 4 and 5. , 2016, European journal of medicinal chemistry.

[16]  Ramalingam Sathishkumar,et al.  Chikungunya infection: A potential re-emerging global threat. , 2016, Asian Pacific journal of tropical medicine.

[17]  Tariq M Rana,et al.  1,2,3-Triazoles as Amide Bioisosteres: Discovery of a New Class of Potent HIV-1 Vif Antagonists. , 2016, Journal of medicinal chemistry.

[18]  L. Ng,et al.  Trisubstituted Thieno[3,2-b]pyrrole 5-Carboxamides as Potent Inhibitors of Alphaviruses. , 2015, Journal of medicinal chemistry.

[19]  J. Masson,et al.  Synthesis and biological evaluation of novel N-phenyl ureidobenzenesulfonate derivatives as potential anticancer agents. Part 2. Modulation of the ring B. , 2015, European journal of medicinal chemistry.

[20]  Jennifer E. Golden,et al.  Development of (E)-2-((1,4-Dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-Amidinophenylbenzamides as Potent Inhibitors of Venezuelan Equine Encephalitis Virus , 2014, Journal of medicinal chemistry.

[21]  L. Delang,et al.  Identification of [1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones as novel inhibitors of Chikungunya virus replication. , 2014, Journal of medicinal chemistry.

[22]  Adel A Rashad,et al.  Chikungunya virus: emerging targets and new opportunities for medicinal chemistry. , 2014, Journal of medicinal chemistry.

[23]  Yuna Sun,et al.  Current progress in antiviral strategies , 2014, Trends in Pharmacological Sciences.

[24]  O. Schwartz,et al.  Identification of Novel Compounds Inhibiting Chikungunya Virus-Induced Cell Death by High Throughput Screening of a Kinase Inhibitor Library , 2013, PLoS neglected tropical diseases.

[25]  Lixin Wu,et al.  Design, synthesis and evaluation of 1,2-benzisothiazol-3-one derivatives as potent caspase-3 inhibitors. , 2013, Bioorganic & medicinal chemistry.

[26]  J. Chu,et al.  Chikungunya virus: an update on antiviral development and challenges , 2013, Drug Discovery Today.

[27]  G. Dobrikov,et al.  Efficient synthesis of new (R)-2-amino-1-butanol derived ureas, thioureas and acylthioureas and in vitro evaluation of their antimycobacterial activity. , 2013, European journal of medicinal chemistry.

[28]  Woody Sherman,et al.  Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments , 2013, Journal of Computer-Aided Molecular Design.

[29]  P. Vidalain,et al.  On dihydroorotate dehydrogenases and their inhibitors and uses. , 2013, Journal of medicinal chemistry.

[30]  L. Kotra,et al.  Design, Synthesis, Biological Evaluation, and Structure–Activity Relationships of Substituted Phenyl 4-(2-Oxoimidazolidin-1-yl)benzenesulfonates as New Tubulin Inhibitors Mimicking Combretastatin A-4 , 2011, Journal of medicinal chemistry.

[31]  Yun Alelyunas,et al.  A high throughput dried DMSO LogD lipophilicity measurement based on 96-well shake-flask and atmospheric pressure photoionization mass spectrometry detection. , 2010, Journal of chromatography. A.

[32]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[33]  Ellen C. Merrick,et al.  2,4(5)-diarylimidazoles as inhibitors of hNaV1.2 sodium channels: pharmacological evaluation and structure-property relationships. , 2009, Bioorganic & medicinal chemistry.

[34]  R. Charrel,et al.  Antiviral treatment of chikungunya virus infection. , 2009, Infectious disorders drug targets.

[35]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[36]  A. Flahault,et al.  On chikungunya acute infection and chloroquine treatment. , 2008, Vector borne and zoonotic diseases.

[37]  K. Onda,et al.  Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors. , 2008, Bioorganic & medicinal chemistry.

[38]  M. Orsale,et al.  High-Throughput Microsomal Stability Assay for Screening New Chemical Entities in Drug Discovery , 2008, Journal of biomolecular screening.

[39]  R. Tesh,et al.  An animal model for studying the pathogenesis of chikungunya virus infection. , 2008, The American journal of tropical medicine and hygiene.

[40]  M. Leung,et al.  Synthesis of Symmetrical and Unsymmetrical N-Aryl-Substituted Cyclic Ureas through Copper(I) Iodide Catalyzed Goldberg-Buchwald-Nandakumar C-N Coupling Reactions , 2008 .

[41]  S. Polyak,et al.  Arbidol: a broad-spectrum antiviral compound that blocks viral fusion. , 2008, Current medicinal chemistry.

[42]  R. Friesner,et al.  Novel procedure for modeling ligand/receptor induced fit effects. , 2006, Journal of medicinal chemistry.

[43]  S. Briolant,et al.  In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination. , 2004, Antiviral research.

[44]  C. Bevan,et al.  A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates. , 2000, Analytical chemistry.

[45]  Gue-Jae Lee,et al.  Regiocontrolled Cyclization Reaction of N-(2-Hydroxyethyl)ureas by Transfer of Activation: One-Pot Synthesis of 2-Imidazolidinones. , 1999, The Journal of organic chemistry.

[46]  Břetislav Rada,et al.  ANTIVIRAL ACTION AND SELECTIVITY OF 6‐AZAURIDINE , 1977, Annals of the New York Academy of Sciences.

[47]  R. Miller,et al.  Mammalian dehydroorotate-ubiquinone reductase complex. , 1968, Canadian journal of biochemistry.

[48]  M. Parida,et al.  Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells. , 2011, Antiviral research.

[49]  Amos B. Smith,et al.  Construction of 5,6-Ring Fused 2-Pyridones: An Effective Annulation Tactic Achieved in Water. , 2009, Synlett : accounts and rapid communications in synthetic organic chemistry.

[50]  V. Mittal,et al.  Chikungunya fever: a re-emerging viral infection. , 2008, Indian journal of medical microbiology.